التفاصيل البيبلوغرافية
| العنوان: |
The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer. |
| المؤلفون: |
Thomas, Daniel C., Arnold, Brian N., Rosen, Joshua E., Salazar, Michelle C., Detterbeck, Frank C., Blasberg, Justin D., Boffa, Daniel J., Kim, Anthony W. |
| المصدر: |
World Journal of Surgery; Jan2018, Vol. 42 Issue 1, p161-171, 11p, 1 Diagram, 3 Charts, 3 Graphs |
| مصطلحات موضوعية: |
NON-small-cell lung carcinoma, SURGICAL excision, CANCER chemotherapy, ADJUVANT treatment of cancer, RADIOTHERAPY, PATIENTS |
| مستخلص: |
Background: Previous literature suggests that patients with non-small cell lung cancer (NSCLC) and unsuspected N2 disease (cN0, pN2) represent a distinct subgroup associated with improved overall survival compared to patients with N2 disease identified prior to resection (cN2, pN2). Methods: Retrospective analysis of the National Cancer Database of patients from 2004 to 2011 with cN0 and cN2 status found to be pathologic stage III-N2 NSCLC after surgical resection. Comparison of 5-year survival of patients with unsuspected N2 disease versus those with known N2 disease after surgical resection using Kaplan-Meier analysis was made. The independent effect of unsuspected N2 disease on mortality was analyzed using multivariate analysis. Results: A total of 3271 patients with pathologic stage III-N2 NSCLC underwent curative intent surgical resection with or without adjuvant chemotherapy or chemotherapy and radiation. Unsuspected N2 disease was identified in 48% of patients. Patients with unsuspected N2 disease were more likely to have T1 tumors (37 vs. 32%, p < 0.001). Unsuspected N2 disease did not impact 5-year overall survival compared with known N2 when adjuvant therapy was utilized (40 vs. 37%, p = 0.167). Multivariate analysis identified older age, higher comorbidity score, and treatment with surgery alone as independent risk factors for mortality. The presence of unsuspected N2 disease was not significant in this model. Conclusions: The findings of this study suggest that unsuspected N2 disease is associated with equivalent 5-year survival compared to cN2 disease when adjuvant therapy is employed. These results support the use of adjuvant chemotherapy and radiation therapy when confronted with unsuspected N2 disease after surgical resection for stage IIIA-NSCLC. [ABSTRACT FROM AUTHOR] |
|
Copyright of World Journal of Surgery is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
